Vivo Capital VIII, LLC (CIK 0001618789)

Latest company ownership

Shares held
1,448,286
Last filed at
Nov 22, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
298,625
Last filed at
Apr 17, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4
Shares held
268,573
Last filed at
Apr 3, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
126,703
Last filed at
Jan 29, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q1 2025Q4
Shares held
30,939
Last filed at
Oct 20, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Apr 1, 2024 Apr 3, 2024 Terns Pharmaceuticals, Inc. 10% Owner Sell 27.5 -420,663 -6.32% ✓ $2.8M
Nov 21, 2023 Nov 22, 2023 Bolt Biotherapeutics, Inc. 10% Owner Sell 52.5 -3,400 -0.09% ✗ $3.1K
Nov 16, 2023 Nov 20, 2023 Bolt Biotherapeutics, Inc. 10% Owner Sell 22.5 -86,054 -1.10% ✗ $79.9K
Dec 23, 2022 Dec 23, 2022 Terns Pharmaceuticals, Inc. 10% Owner Buy 100.0 +758,620 12.86% ✗ $5.5M
Sep 7, 2022 Sep 8, 2022 Terns Pharmaceuticals, Inc. 10% Owner Buy 100.0 +600,000 11.32% ✗ $2.2M
Aug 12, 2022 Aug 16, 2022 Terns Pharmaceuticals, Inc. 10% Owner Buy 100.0 +2,624,239 63.15% ✗ $7M
Feb 9, 2021 Feb 9, 2021 Bolt Biotherapeutics, Inc. 10% Owner Buy 96.3 +349,774 9.93% ✗ $7M
Feb 9, 2021 Feb 9, 2021 Terns Pharmaceuticals, Inc. 10% Owner Buy 100.0 +475,000 21.59% ✗ $8.1M
Oct 20, 2020 Oct 20, 2020 Aligos Therapeutics, Inc. 10% Owner Buy 100.0 +550,000 18.35% ✗ $8.3M
Apr 15, 2020 Apr 17, 2020 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 16.3 -330,598 -4.18% ✗ $5.1M
Apr 3, 2020 Apr 7, 2020 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 17.5 -306,115 -5.19% ✗ $4.2M
Mar 9, 2020 Mar 11, 2020 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 51.3 -528 -0.02% ✗ $10.3K
Feb 7, 2020 Feb 11, 2020 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 37.5 -13,460 -0.21% ✗ $291.6K
Feb 4, 2020 Feb 6, 2020 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 37.5 -13,460 -0.41% ✗ $306.9K
Jan 29, 2020 Jan 31, 2020 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 37.5 -26,920 -0.27% ✗ $594.2K
Mar 20, 2019 Mar 25, 2019 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 16.3 -417,000 -11.16% ✗ $9.3M
Jul 20, 2018 Jul 20, 2018 Crinetics Pharmaceuticals, Inc. 10% Owner Buy 100.0 +353,180 10.02% ✗ $6.6M
Jan 25, 2018 Jan 29, 2018 VYNE Therapeutics Inc. 10% Owner Buy 100.0 +294,118 100.00% ✗ $5M